Related Experiment Video
Updated: May 8, 2026
04:30
A Murine Model of Stent Implantation in the Carotid Artery for the Study of Restenosis
Published on: May 14, 2013
Statins, percutaneous coronary intervention and myocardial infarction
1Heart of England NHS Foundation Trust, Birmingham Heartlands Hospital , Birmingham , UK.
Current Medical Research and Opinion
|September 12, 2013
Summary
A supplemental statin dose before percutaneous coronary intervention (PCI) significantly reduced myocardial infarction risk in patients already on statins. This suggests a potential benefit of a single statin dose for all PCI patients.
Area of Science:
- Cardiology
- Interventional Cardiology
- Pharmacology
Background:
- Peri-procedural myocardial infarction (MI) complicates up to 40% of percutaneous coronary intervention (PCI) procedures, leading to poorer long-term outcomes.
- Statins administered around PCI can mitigate MI risk, but their widespread use in at-risk patients complicates this strategy.
Discussion:
- This study investigated the efficacy of a single high-dose atorvastatin given pre-PCI to patients already on chronic statin therapy.
- The findings demonstrate a significant reduction in peri-procedural MI incidence within this patient cohort.
Key Insights:
- A supplemental, high-dose statin regimen prior to PCI significantly lowers the risk of peri-procedural myocardial infarction.
- This strategy proves effective even in patients already receiving long-term statin treatment.
Outlook:
- Consideration of a single, supplemental statin dose for all patients undergoing PCI may offer clinical advantages.
- Further research could explore optimal dosing and timing for this supplemental statin strategy in diverse patient populations.
Related Concept Videos
01:27Coronary Artery Disease V: Interprofessional Care
Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...
01:28Acute Coronary Syndrome IV: Interprofessional Care
IntroductionThe management of Acute Coronary Syndrome (ACS) aims to minimize myocardial damage, preserve myocardial function, and prevent complications.Initial ManagementInpatient management involves continuous cardiac monitoring, preferably in an ICU, focusing on blood pressure, serum sodium, potassium, and creatinine levels, and urine output. Ongoing pharmacologic management is crucial for stabilizing the patient.Supplemental Oxygen: Administer supplemental oxygen if oxygen saturation is...
01:26Angina IV: Management
IntroductionThe management of angina requires a comprehensive approach that includes pharmacological therapies, medical procedures, and lifestyle modifications.Pharmacological TherapiesAntiplatelet agents, such as aspirin, clopidogrel, prasugrel, and ticagrelor, play a pivotal role in preventing thrombus formation in patients with angina. These medications inhibit platelet aggregation and reduce the likelihood of myocardial infarction and other cardiovascular events.Anticoagulants, including...
01:26Atherosclerosis III: Management
Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
01:20Lipid-Lowering Drugs: Statins and Miscellaneous Agents
Hyperlipidemia, a medical condition often referred to as high cholesterol, is characterized by abnormally elevated levels of lipids in the bloodstream. When present in excess, these lipids, specifically cholesterol and triglycerides, can lead to serious health complications, often involving cardiovascular diseases. Illnesses like atherosclerosis, heart attacks, and pancreatitis have all been linked to untreated hyperlipidemia. This means controlling and regulating cholesterol and triglyceride...
01:27Peripheral Artery Disease III: Interprofessional Care
Peripheral Artery Disease (PAD) is characterized by narrowed arteries that diminish blood flow to the extremities. Effective management of PAD requires an interprofessional approach involving various healthcare professionals. The critical aspects of interprofessional care for PAD patients focus on risk factor modification, drug therapy, exercise therapy, nutrition therapy, critical limb ischemia care, and interventional radiology and surgical procedures.The primary treatment goal for PAD...